Impact of early (3 months) dual antiplatelet treatment interruption prior to renal transplantation in patients with second-generation DES on perioperative stent thrombosis and MACEs

dc.contributor.author	Doğan, Ali
dc.contributor.author	Özdemir, Emrah
dc.contributor.author	Kahraman, Serkan
dc.contributor.author	Açıl, Tayfun
dc.contributor.author	Saltan, Yelda
dc.contributor.author	Kurtoğlu, Nuri
dc.date.accessioned	2021-12-21T08:31:10Z
dc.date.available	2021-12-21T08:31:10Z
dc.date.issued	2017
dc.identifier.issn	2149-2263
dc.identifier.issn	2149-2271
dc.identifier.uri	https://app.trdizin.gov.tr/makale/TWpZNE5Ua3dNQT09/impact-of-early-3-months-dual-antiplatelet-treatment-interruption-prior-to-renal-transplantation-in-patients-with-second-generation-des-on-perioperative-stent-thrombosis-and-maces
dc.identifier.uri	http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/593
dc.description.abstract	Objective: Early cessation of dual antiplatelet therapy (DAPT) is related to stent thrombosis (ST). The use of second-generation everolimus- and zotarolimus-eluting stents is associated with low restenosis rates and short duration of clopidogrel usage. No
dc.language.iso	English
dc.title	Impact of early (3 months) dual antiplatelet treatment interruption prior to renal transplantation in patients with second-generation DES on perioperative stent thrombosis and MACEs
dc.relation.journal	The Anatolian Journal of Cardiology
dc.identifier.issue	6
dc.identifier.startpage	391
dc.identifier.endpage	396
dc.identifier.volume	18
dc.relation.issue	6
dc.relation.volume	18